BMAT

The BioMedical Admissions Test, commonly known as BMAT, is an internationally recognised subject-specific admissions test designed for students applying to medicine, veterinary medicine, biomedical sciences, and dentistry courses at leading universities worldwide. Previously conducted by Cambridge Assessment Admissions Testing, the exam has undergone significant transitions, with the last BMAT examination held in 2023 before its discontinuation by Cambridge Assessment. The BioMedical Admissions Test was specifically designed to assess aptitude and subject knowledge in areas critical for success in medical and biomedical degree programmes. The test evaluated candidates' scientific reasoning, problem-solving abilities, critical thinking, and written communication skills. Top participating institutions historically included the University of Cambridge, Imperial College London, University of Oxford (for some courses), University College London (UCL), Leeds School of Medicine, Lancaster University Medical School, and various European institutions including universities in Spain, the Netherlands, and Singapore. For Indian students and international candidates who previously relied on BMAT for admissions, many institutions have now transitioned to alternative admissions tests such as the University Clinical Aptitude Test (UCAT), institution-specific assessments, or modified entry requirements. The BioMedical Admissions Test comprised three sections testing aptitude and skills, scientific knowledge and applications, and writing task, with a total duration of two hours.